Pfizer Beats Q2 Expectations with Revenue and EPS Surprise Pfizer Inc. (PFE) surpassed Wall Street expectations in Q2 2025, delivering $14.7 billion in revenue versus consensus estimates of $13.5 billion, and reporting Earnings Per Share (EPS) of $0.78, well ahead of the ...